Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-19-013085)

Filing Details

Accession Number:: 0001213900-19-013085
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-07-18 13:31:26
Reporting Period:: 2019-07-16

Accepted Time:: 2019-07-18 13:31:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1176309	Oramed Pharmaceuticals Inc.	ORMP	Pharmaceutical Preparations (2834)	980376008

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1416089	Leonard Sank	3 Blair Road Cape Town T3 8005		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-07-16	20,000	$3.47	315,482	No	4	P	Direct
Common Stock	Acquisiton	2019-07-17	20,000	$3.58	335,482	No	4	P	Direct
Common Stock	Acquisiton	2019-07-17	10,020	$3.74	345,502	No	4	P	Direct
Common Stock	Acquisiton	2019-07-18	4,497	$3.86	349,999	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	78,125	Indirect	Via spouse
Common Stock	138,889	Indirect	Via trust

Footnotes

Mr. Sank disclaims beneficial ownership of these shares.
These shares consist of shares of common stock owned by a company wholly owned by a trust of which Mr. Sank is a trustee. Mr. Sank disclaims beneficial ownership of these shares.